Introduction
============

Frailty is a geriatric syndrome and is commonly defined as a clinically recognizable state in older adults. It is associated with increased vulnerability that is resulted from aging-associated declines in physiologic reserve and function across multiple organs and systems.[@b1-cia-14-105]--[@b5-cia-14-105] Frailty is highly prevalent with increasing age and gives rise to high risk for adverse health outcomes, including falls, hospitalization, and mortality.

The concept and definition of frailty is still evolving. One of the approaches to frailty is the frailty phenotype,[@b3-cia-14-105] which contains unintentional weight loss, exhaustion, weakness, slowness, and low physical activity. It is estimated that 10%--27% of the population over 65 years is frail by the definition of a combination of any three phenotypes.[@b6-cia-14-105] Another approach defines frailty as a stage of age-related deficit accumulation and quantify the frail state using a "frail index", which is the ratio of present deficits to the ones evaluated.[@b7-cia-14-105] Both approaches to frailty have been extensively used and adapted in animal studies and clinical trials. Due to the lack of subcellular mechanisms and effective biomarkers, a consensus has not been reached in the concept of frailty.

Malnutrition is very common in hospitalized older patients with a prevalence up to 50%.[@b8-cia-14-105],[@b9-cia-14-105] Poor nutritional status has been shown to be associated with adverse clinical outcomes in older patients, such as decreased physical functions and increased mortality.[@b10-cia-14-105],[@b11-cia-14-105] In recent years, the relationship between frailty and malnutrition in community-dwelling older people has been demonstrated.[@b12-cia-14-105]--[@b15-cia-14-105] However, this relationship in hospitalized older patients has not been investigated.

Our study aimed to compare the nutritional status and physical functions between nonfrail, prefrail, and frail hospitalized older patients and identify possible biomarkers for the evaluation of nutritional status and frailty.

Materials and methods
=====================

Study design
------------

This is a cross-sectional study analyzing the clinical data of hospitalized older patients treated at the geriatric ward of Zhejiang Hospital between January 2017 and June 2018. The inclusion criteria were as follow: age ≥65 years, ability to understand and communicate in Chinese, ability to walk without assistance except walking aids, and hearing and vision sufficient for compliance with assessment. The exclusion criteria were as follow: acute infection, malignant tumor, cerebellum diseases, acute cerebrovascular diseases, delirium, terminal illness, or severe cognitive impairment (Mini-Mental State Examination \[MMSE\] \<12). A total of 380 patients were included in the final analysis ([Figure 1](#f1-cia-14-105){ref-type="fig"}). Our study was conducted in accordance with the Declaration of Helsinki and was approved by the Research Ethics Committee of Zhejiang Hospital. Written informed consent was obtained from each participant.

Patient assessment
------------------

A comprehensive geriatric assessment (CGA) and frailty assessment were given to each qualified patient by a geriatric nurse and a geriatrician in our ward within 3 days after admission. The main content of CGA includes a general health questionnaire, assessment of activities of daily living (ADL),[@b16-cia-14-105] instrumental ADL (IADL),[@b17-cia-14-105] MMSE,[@b18-cia-14-105] mini nutritional assessment-short form (MNA-SF),[@b19-cia-14-105] and Tinetti performance-oriented mobility assessment (POMA).[@b20-cia-14-105] Grip strength, fall history in the past year, and polypharmacy were recorded. Serum levels of transferrin (TFN), prealbumin (PA), total protein (TP), albumin (ALB), retinol-binding protein (RBP), and hemoglobin (Hb) were measured and recorded. Sociodemographic data including age, gender, educational level, body weight, and height were collected.

Assessment of frailty status
----------------------------

The Fried criterion, also known as the frailty phenotype, was used to assess the frailty status. Frailty phenotype with the five items is the most extensively used and tested criteria for its validity. These criteria are mentioned below. Unintentional weight loss over 4.5 kg or 5% of body weight during the last year.Decrease in the grip strength measured by Jamar dynamometer. The patient is sitting in the chair with the shoulders adducted, the elbows flexed to 90°, and the forearms in neutral position. Three measurements are made with 1-minute intervals, and the mean value of the three measurements is calculated. All values are adjusted for gender and body mass index (BMI). The criteria for weakness in women are the strength ≤17 kg for BMI of ≤23, ≤17.3 kg for BMI between 23.1 and 26, ≤18 kg for BMI between 26.1 and 29, and ≤21 kg for BMI \>29. For men, the adjusted values are ≤29 kg for BMI of ≤24, ≤30 kg for BMI between 24.1 and 26, 30 kg for BMI between 26.1 and 28, and ≤32 kg for BMI \>28.Self-reported exhaustion. Self-reported feeling that everything is an effort or that one could not get "going" \>2 times a week.Slow walking speed. It is also adjusted for gender and the height of the patient regardless of whether a walking aid is used or not. For men with a height ≤173 cm, ≥7 seconds of walking through a distance of 4.57 m and for men with a height \>173 cm, ≥6 seconds are assumed as slow speed. For women, slow speed is ≥7 seconds for those with a height ≤159 cm and ≥6 seconds for those with a height \>159 cm (distance is same in all cases).Low physical activity level. The criteria are \<383 kcal/week for men and \<270 kcal/week for women. All participants were diagnosed according to the frailty phenotype. One point for each item: 0 = not frail; 1--2 = prefrail; ≥3 = frail.

Assessment of nutritional status
--------------------------------

The MNA-SF was used for the assessment of nutritional status, which has been validated for malnutrition screening in frail older people.[@b21-cia-14-105] The MNA-SF includes six items: 1) weight loss in the last 3 months: \>3 kg = 0, unknown = 1, 1--3 kg = 2, no = 3; 2) BMI: \<19 = 0, 19--21 = 1, 21--23 = 2, \>23 = 3; 3) psychological stress or acute disease: no = 0, yes = 2; 4) mobility: long-term bedridden = 0, capability but unwillingness of activities = 1, outdoor activities = 2; 5) neuropsychological problems: severe dementia or depression = 0, mild dementia or depression = 1, no = 2; 6) food intake: significant decrease in food intake = 0, mild decrease in food intake = 1, no = 2. The maximum total score is 14 points. A total score of 12--14 points indicate well nourishment, 8--11 points indicate risk of malnutrition, and 0--7 points indicate malnourishment.

Data collection
---------------

Sociodemographic data including age, gender, educational level, weight, and height were collected. Information about the frailty status and medication was collected by reviewing the medical records. Polypharmacy was defined as not less than five kinds of oral prescription drugs.[@b22-cia-14-105] The ADL, IADL, and POMA were used to assess functional status. The cognitive status was evaluated using the MMSE. The MNA-SF and levels of serum TFN, PA, TP, ALB, RBP, and Hb were used to assess the nutritional status. Venous blood samples were collected in the early morning from the fasting patients and tested in a laboratory of Zhejiang Hospital. Some categorical variables, such as gender, educational level, polypharmacy, fall history, frailty status, and nutritional status, were reassigned. Continuous variables such as TFN, PA, TP, ALB, RBP, and Hb were reassigned into three grades with a cutoff from the lowest value to the percentile 25, the percentile 25 to the percentile 75, and the percentile 75 to the highest value ([Table S1](#SD1-cia-14-105){ref-type="supplementary-material"}).

Statistical analysis
--------------------

The normally distributed continuous data were presented as mean and SDs, and the nonnormally distributed continuous data were presented as medians and IQR. Categorical variables were presented as percentages or constituent ratios. When three groups were considered, the one-way ANOVA test (for normally distributed continuous data), the Pearson's chi-squared test (for categorical data), and the Kruskal--Wallis test (for nonnormally distributed continuous data) were used for the comparison. When two groups were considered, the least significant difference (LSD) *t*-test (for normally distributed continuous data), the chi-squared test (for categorical data), and the Mann--Whitney *U*-test (for nonnormally distributed continuous data) were used for the comparison. As a secondary analysis, binary classification of frailty (nonfrail vs prefrail/frail) was treated as the dependent variable, and other assessments were treated as the continuous variables. The relationship between frailty and risk factors was analyzed using the univariate logistic regression analysis. Ordinal logistic regression analysis was used for further analysis of the relationship between frailty status and nutritional status as well as nutrition-related biomarkers, adjusting age, gender, BMI, polypharmacy, fall history, and grip strength. ORs were reported for significant associations. All statistical analyses were performed using the SPSS 22.0 software (IBM Corporation, Armonk, NY, USA). All significance tests were two-tailed, and statistical significance was assumed as *P*\<0.05.

Results
=======

Our patients included 140 nonfrail patients (36.8%), 81 prefrail patients (21.3%), and 159 frail patients (41.9%). The grip strength, levels of serum TFN, TP, ALB, Hb, and scores of MNA-SF, ADL, IADL, MMSE, POMA decreased significantly in the order of nonfrail, prefrail, and frail groups (*P*\<0.01). Patients in the prefrail and frail groups were significantly older, more likely to have falls in the past year and had significantly higher polypharmacy rate in comparison with the nonfrail patients (*P*\<0.05, [Table 1](#t1-cia-14-105){ref-type="table"}).

The risk factors that may be associated with frailty were analyzed using the univariate logistic regression analysis. The results showed that the frailty status was positively related to age, polypharmacy, fall history, nutritional status, levels of TFN, PA, TP, ALB, RBP, and Hb, but was negatively related to grip strength ([Table 2](#t2-cia-14-105){ref-type="table"}). Ordinal logistic regression analysis showed that older patients who were well nourished and had higher levels of TFN, TP, and ALB were less likely to develop into frailty ([Table 3](#t3-cia-14-105){ref-type="table"}).

Discussion
==========

Our study demonstrated that older hospitalized patients with better nutritional status and higher serum levels of TFN, TP, and ALB were less likely to develop into frailty. In the order of nonfrail, prefrail, and frail groups, the patients were older, with decreased grip strength, scores of ADL, IADL, MMSE, POMA, MNA-SF, higher rates of polypharmacy, and more likely to have falls in the past year. Our results were consistent with previous findings.[@b14-cia-14-105],[@b23-cia-14-105],[@b24-cia-14-105] However, we found no significant difference in the educational level between groups of different frailty status, which was not consistent with previous findings.[@b23-cia-14-105],[@b24-cia-14-105] The possible reason underlying this discrepancy may be that the classification criteria of educational level in our study were different from that in the previous studies. In addition, educational level was not a direct risk factor of frailty.

The frailty status was categorized into nonfrailty, pre-frailty, and frailty. Each risk factor that might be associated with frailty was analyzed using the univariate logistic regression analysis. Our study found that frailty status was positively related to age, polypharmacy, fall history, nutritional status, serum levels of TFN, PA, TP, ALB, RBP, and Hb, but was negatively related to grip strength. The ordinal logistic regression analysis showed that older patients who were well nourished and had higher serum levels of TFN, TP, and ALB were less likely to develop into frailty with adjustment of age, gender, BMI, polypharmacy, fall history, and grip strength. Previous studies have shown that there was a close relationship between nutritional status and frailty.[@b14-cia-14-105],[@b15-cia-14-105],[@b25-cia-14-105],[@b26-cia-14-105] Soysal et al[@b27-cia-14-105] has demonstrated that the MNA can be used to detect frailty with a sensitivity of 66.9% and a specificity of 85.4%, suggesting a very close relationship between the nutritional status and frailty.

Protein--energy homeostasis is a major determinant of healthy aging. It has been shown that lower protein intake was associated with a higher frailty prevalence.[@b28-cia-14-105]--[@b31-cia-14-105] Consistently, our study found that significantly higher serum levels of nutrition-related proteins were observed in the nonfrail patients compared to the prefrail and frail patients. In addition, ordinal logistic regression analysis also showed that patients with higher serum levels of TFN, TP, and ALB were less likely to develop into frailty. Although the association between serum levels of PA, RBP, Hb, and frailty was not found in our study, significant differences in these biomarkers did exist between the three groups. Deficiency of other important nutritional determinants, such as vitamin B12, is also found to be associated with frailty.[@b32-cia-14-105]

Our study has limitations. First, our study is a cross-sectional study and does not support causality conclusions. Second, generalization of our results should be cautious because the participants were from one hospital rather than multiple centers. Third, there are overlapping items between the frailty phenotype and MNA-SF.

Conclusion
==========

Older hospitalized patients who were well nourished and had higher serum levels of TFN, TP, and ALB were less likely to develop into frailty. These nutrition-related biomarkers might be used for screening frailty in older patients.

Supplementary material
======================

###### 

Reassignment of the variables

  Variable             Group                                  Value
  -------------------- -------------------------------------- -------
  Gender               Female                                 0
                       Male                                   1
  Educational level    High level (12 years)                  0
                       Middle level (7--12 years)             1
                       Low level (0--6 years)                 2
  Polypharmacy         Negative                               0
                       Positive                               1
  Fall history         Negative                               0
                       Positive                               1
  Frail status         Nonfrail (Fried frail index: 0)        0
                       Prefrail (Fried frail index: 1--2)     1
                       Frail (Fried frail index: 3--5)        2
  Nutritional status   Well nourished (MNA-SF: 12--14)        0
                       Risk of malnutrition (MNA-SF: 8--11)   1
                       Malnutrition (MNA-SF: 0--7)            2
  TFN level            High level (\>3.36 g/L)                0
                       Middle level (2.02--3.36 g/L)          1
                       Low level (\<2.02 g/L)                 2
  PA level             High level (\>250 mg/L)                0
                       Middle level (187--250 mg/L)           1
                       Low level (\<187 mg/L)                 2
  TP level             High level (\>70.81 g/L)               0
                       Middle level (62.57--70.81 g/L)        1
                       Low level (\<62.57 g/L)                2
  ALB level            High level (\>42.56 g/L)               0
                       Middle level (36.24--42.56 g/L)        1
                       Low level (\<36.24 g/L)                2
  RBP level            High level (\>47.40 mg/L)              0
                       Middle level (33.46--47.40 mg/L)       1
                       Low level (\<33.46 mg/L)               2
  Hb level             High level (\>129 g/L)                 0
                       Middle level (112--129 g/L)            1
                       Low level (\<112 g/L)                  2

**Abbreviations:** ALB, albumin; Hb, hemoglobin; MNA-SF, mini nutritional assessment-short form; PA, prealbumin; RBP, retinol-binding protein; TNF, transferrin; TP, total protein.
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###### 

Comparison of patients' characteristics based on frailty status

  Characteristics                           Nonfrailty (n=140)   Prefrailty (n=81)                                         Frailty (n=159)                                                                                      *P*-value
  ----------------------------------------- -------------------- --------------------------------------------------------- ---------------------------------------------------------------------------------------------------- ---------------------------------------------------
  **Demographic**                                                                                                                                                                                                               
  Age (years)                               77.69±7.67           85.43±6.21[\*](#tfn5-cia-14-105){ref-type="table-fn"}     86.75±5.80[Δ](#tfn6-cia-14-105){ref-type="table-fn"}                                                 \<0.001[a](#tfn2-cia-14-105){ref-type="table-fn"}
  Male (%)                                  51 (57.9)            43 (53.1)                                                 93 (58.5)                                                                                            0.710[b](#tfn3-cia-14-105){ref-type="table-fn"}
  BMI (kg/m^2^)                             23.60±3.13           23.33±4.56                                                23.39±4.11                                                                                           0.857[a](#tfn2-cia-14-105){ref-type="table-fn"}
  Educational level (high/middle/low) (%)   30.7/47.1/22.1       29.6/49.4/21.0                                            34.6/47.2/18.2                                                                                       0.582[b](#tfn3-cia-14-105){ref-type="table-fn"}
  **Medical**                                                                                                                                                                                                                   
  Cardiovascular disease (%)                78 (55.7)            45 (55.5)                                                 90 (56.6)                                                                                            0.173[b](#tfn3-cia-14-105){ref-type="table-fn"}
  Cerebrovascular disease (%)               33 (23.6)            18 (22.2)                                                 30 (18.8)                                                                                            0.102[b](#tfn3-cia-14-105){ref-type="table-fn"}
  Diabetes (%)                              15 (10.7)            10 (12.3)                                                 19 (11.9)                                                                                            0.093[b](#tfn3-cia-14-105){ref-type="table-fn"}
  Fall history (%)                          19 (13.6)            17 (21.0)                                                 44 (27.7)[Δ](#tfn6-cia-14-105){ref-type="table-fn"}                                                  0.011[b](#tfn3-cia-14-105){ref-type="table-fn"}
  Grip strength (kg)                        30.76±8.86           22.81±7.30[\*](#tfn5-cia-14-105){ref-type="table-fn"}     21.36±7.58[Δ](#tfn5-cia-14-105){ref-type="table-fn"},[\#](#tfn7-cia-14-105){ref-type="table-fn"}     \<0.001[a](#tfn2-cia-14-105){ref-type="table-fn"}
  Polypharmacy (%)                          50 (35.7)            54 (66.7)[\*](#tfn5-cia-14-105){ref-type="table-fn"}      118 (74.2)[Δ](#tfn6-cia-14-105){ref-type="table-fn"}                                                 \<0.001[b](#tfn3-cia-14-105){ref-type="table-fn"}
  MNA-SF                                    13 (12--14)          12 (11--14)[\*](#tfn5-cia-14-105){ref-type="table-fn"}    11 (10--13)[Δ](#tfn5-cia-14-105){ref-type="table-fn"},[\#](#tfn7-cia-14-105){ref-type="table-fn"}    \<0.001[c](#tfn4-cia-14-105){ref-type="table-fn"}
  ADL                                       100 (100--100)       100 (95--100)                                             90 (75--100)[Δ](#tfn5-cia-14-105){ref-type="table-fn"},[\#](#tfn7-cia-14-105){ref-type="table-fn"}   \<0.001[c](#tfn4-cia-14-105){ref-type="table-fn"}
  IADL                                      8 (8--8)             7 (5--8)[\*](#tfn5-cia-14-105){ref-type="table-fn"}       3 (2--5)[Δ](#tfn5-cia-14-105){ref-type="table-fn"},[\#](#tfn7-cia-14-105){ref-type="table-fn"}       \<0.001[c](#tfn4-cia-14-105){ref-type="table-fn"}
  MMSE                                      27 (25--29)          25 (22--27)[\*](#tfn5-cia-14-105){ref-type="table-fn"}    23 (18--27)[Δ](#tfn6-cia-14-105){ref-type="table-fn"}                                                \<0.001[c](#tfn4-cia-14-105){ref-type="table-fn"}
  POMA                                      26 (25--28)          21 (17--24)[\*](#tfn5-cia-14-105){ref-type="table-fn"}    18 (15--23)[Δ](#tfn5-cia-14-105){ref-type="table-fn"},[\#](#tfn7-cia-14-105){ref-type="table-fn"}    \<0.001[c](#tfn4-cia-14-105){ref-type="table-fn"}
  **Serum biomarkers**                                                                                                                                                                                                          
  TFN (g/L)                                 2.37±0.30            2.08±0.28[\*](#tfn5-cia-14-105){ref-type="table-fn"}      2.06±0.26[Δ](#tfn6-cia-14-105){ref-type="table-fn"}                                                  \<0.001[a](#tfn2-cia-14-105){ref-type="table-fn"}
  PA (mg/L)                                 237.89±47.56         201.91±40.16[\*](#tfn5-cia-14-105){ref-type="table-fn"}   212.07±48.26[Δ](#tfn6-cia-14-105){ref-type="table-fn"}                                               \<0.001[a](#tfn2-cia-14-105){ref-type="table-fn"}
  TP (mg/L)                                 69.88±4.43           66.02±5.23[\*](#tfn5-cia-14-105){ref-type="table-fn"}     62.76±4.60[Δ](#tfn6-cia-14-105){ref-type="table-fn"}                                                 \<0.001[a](#tfn2-cia-14-105){ref-type="table-fn"}
  ALB (g/L)                                 41.71±3.27           38.10±4.44[\*](#tfn5-cia-14-105){ref-type="table-fn"}     38.07±3.87                                                                                           \<0.001[a](#tfn2-cia-14-105){ref-type="table-fn"}
  RBP (mg/L)                                42.96±10.12          39.59±11.77                                               40.38±12.25                                                                                          0.063[a](#tfn2-cia-14-105){ref-type="table-fn"}
  Hb (g/L)                                  125.45±8.73          119.54±12.25[\*](#tfn5-cia-14-105){ref-type="table-fn"}   117.33±11.83[Δ](#tfn6-cia-14-105){ref-type="table-fn"}                                               \<0.001[a](#tfn2-cia-14-105){ref-type="table-fn"}

**Notes:** Three groups were considered:

one-way ANOVA;

Pearson's chi-squared test;

Kruskal--Walls test. Two groups were considered: LSD *t*-test (for normally distributed continuous data), chi-squared test (for categorical data), Mann--Whitney *U*-test (for nonnormally distributed continuous data).

*P*\<0.05, prefrail vs nonfrail;

*P*\<0.05, frail vs nonfrail;

*P*\<0.05, frail vs prefrail.

**Abbreviations:** ADL, activities of daily living; ALB, albumin; BMI, body mass index; Hb, hemoglobin; IADL, instrumental ADL; MMSE, Mini-Mental State Examination; MNA-SF, mini nutritional assessment-short form; PA, prealbumin; POMA, performance-oriented mobility assessment; RBP, retinol-binding protein; TNF, transferrin; TP, total protein.

###### 

Risk factors associated with frailty

  Risk factors         Frailty                *P*-value
  -------------------- ---------------------- -----------
  Age                  1.187 (1.144--1.232)   \<0.001
  Gender               0.953 (0.625--1.452)   0.821
  BMI                  0.985 (0.933--1.040)   0.585
  Polypharmacy         4.553 (2.917--7.107)   0.001
  Fall history         2.165 (1.230--3.810)   0.007
  Grip strength        0.878 (0.851--0.906)   \<0.001
  Nutritional status   3.003 (1.953--4.616)   \<0.001
  TFN                  4.307 (2.966--6.254)   \<0.001
  PA                   2.440 (1.745--3.411)   \<0.001
  TP                   3.919 (2.723--5.640)   \<0.001
  ALB                  4.069 (2.820--5.873)   \<0.001
  RBP                  1.528 (1.129--2.067)   0.006
  Hb                   2.879 (2.055--4.034)   \<0.001

**Note:** Each risk factor was analyzed using the univariate logistic regression analysis.

**Abbreviations:** ALB, albumin; BMI, body mass index; Hb, hemoglobin; PA, prealbumin; RBP, retinol-binding protein; TNF, transferrin; TP, total protein.

###### 

Relationship between frailty status and risk factors

  Risk factor              Fried score                                    Standard error   Wald     95% CI             *P*−value
  ------------------------ ---------------------------------------------- ---------------- -------- ------------------ -----------
  Age                      0.084                                          0.020            17.882   0.045 to 0.123     \<0.001
  Gender = 0               −0.615                                         0.351            3.066    −1.304 to 0.073    0.080
  Gender = 1               0[a](#tfn12-cia-14-105){ref-type="table-fn"}                                                
  BMI                      0.072                                          0.033            4.776    0.007 to 0.136     0.029
  Polypharmacy = 0         −1.244                                         0.268            21.547   −1.770 to −0.719   \<0.001
  Polypharmacy = 1         0[a](#tfn12-cia-14-105){ref-type="table-fn"}                                                
  Fall history = 0         −0.173                                         0.317            0.296    −0.795 to 0.450    0.587
  Fall history = 0         0[a](#tfn12-cia-14-105){ref-type="table-fn"}                                                
  Grip strength            −0.113                                         0.022            27.656   −0.155 to −0.071   \<0.001
  Nutritional status = 0   −2.405                                         0.718            11.200   −3.813 to −0.996   0.001
  Nutritional status = 1   −1.066                                         0.708            2.269    −2.453 to 0.321    0.132
  Nutritional status = 2   0[a](#tfn12-cia-14-105){ref-type="table-fn"}                                                
  TFN = 0                  −1.333                                         0.415            10.318   −2.147 to −0.520   0.001
  TFN = 1                  −0.490                                         0.328            2.238    −1.133 to 0.152    0.135
  TFN = 2                  0[a](#tfn12-cia-14-105){ref-type="table-fn"}                                                
  PA = 0                   0.114                                          0.386            0.088    −0.642 to 0.870    0.767
  PA = 1                   0.034                                          0.295            0.013    −0.543 to 0.612    0.908
  PA = 2                   0[a](#tfn12-cia-14-105){ref-type="table-fn"}                                                
  TP = 0                   −0.038                                         0.016            5.353    −0.070 to −0.006   0.021
  TP = 1                   −0.284                                         0.329            0.742    −0.930 to 0.362    0.389
  TP = 2                   0[a](#tfn12-cia-14-105){ref-type="table-fn"}                                                
  ALB = 0                  −0.952                                         0.343            7.710    −1.624 to −0.280   0.005
  ALB = 1                  −0.798                                         0.428            3.483    −1.637 to 0.040    0.062
  ALB = 2                  0[a](#tfn12-cia-14-105){ref-type="table-fn"}                                                
  RBP = 0                  0.495                                          0.366            1.830    −0.222 to 1.212    0.176
  RBP = 1                  0.070                                          0.294            0.057    −0.507 to 0.647    0.812
  RBP = 2                  0[a](#tfn12-cia-14-105){ref-type="table-fn"}                                                
  Hb = 0                   −0.616                                         0.391            2.478    −1.382 to 0.151    0.115
  Hb = 1                   −0.443                                         0.325            1.857    −1.079 to 0.194    0.173
  Hb = 2                   0[a](#tfn12-cia-14-105){ref-type="table-fn"}                                                

**Notes:** All data were analyzed by ordinal logistic regression analysis with adjustment for age, gender, BMI, polypharmacy, fall history, and grip strength.

This parameter is set zero because it is redundant.

**Abbreviations:** ALB, albumin; BMI, body mass index; Hb, hemoglobin; PA, prealbumin; RBP, retinol-binding protein; TNF, transferrinl; TP, total protein.
